台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    70.1
  • 漲跌
    ▼0.2
  • 漲幅
    -0.28%
  • 成交量
    109
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-元大-台北 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-台北 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/0300.000.370.0070.10-0.3259-0.12%
2024/04/3000.00568.5271.30-5258-1.93%
2024/04/2300.000.564.5068.00-0.5256-0.20%
2024/04/1000.00167.1067.10-1254-0.39%
2024/04/0100.00169.5069.90-1247-0.40%
2024/03/2700.00269.5069.00-2244-0.82%
2024/03/2200.000.362.5064.30-0.3230-0.13%
2024/03/08162.0000.0061.0012140.47%
2024/02/201048.3000.0048.30101805.53%
2024/02/191752.0000.0052.50171849.23%
2024/02/162252.6600.0052.002218312.00%
2024/02/01343.800.543.4543.852.51531.63%
2023/12/2900.00441.4541.30-4238-1.67%
2023/11/1300.000.433.6534.20-0.4154-0.26%
2023/11/0200.00129.5030.00-1138-0.72%
2023/07/1100.000.721.3522.25-0.778-0.89%
2023/05/2200.00320.3520.35-3110-2.73%
2023/03/0900.004.216.4716.35-4.216-24.85%
2023/01/1200.000.415.8516.00-0.410-3.79%
2022/10/1900.00113.9514.25-1115-0.87%
2021/05/2000.00116.9016.60-1550-0.18%
2021/05/17319.10119.6519.6025060.40%
2021/05/13519.0000.0019.5554341.15%
2021/03/1600.00216.4016.45-2269-0.74%
2021/02/2300.00118.4017.45-1193-0.52%
2021/01/20116.0000.0015.8012100.47%
2020/11/0200.00118.6518.65-1470-0.21%
2020/10/2600.00220.6020.40-2528-0.38%
2020/10/22322.8500.0021.2035610.53%
2020/10/2100.00221.7521.75-2544-0.37%
2020/10/20219.7500.0019.8025460.37%
2020/08/2500.00620.2520.30-61,954-0.31%
2020/08/06924.8000.0024.3092,3020.39%
2020/08/0400.00225.7025.50-22,278-0.09%
2020/07/29125.0000.0025.5512,2730.04%
2020/07/2300.00128.8028.80-12,233-0.04%
2020/07/2100.00127.2527.45-12,149-0.05%
2020/07/20125.0000.0025.0012,1090.05%
2020/07/1700.00327.5226.15-32,068-0.15%
2020/07/1500.00130.0530.80-11,983-0.05%
2020/07/141232.25131.2029.60111,9070.58%
2020/07/13430.73831.1831.55-41,793-0.22%
2020/07/10728.69728.7028.7001,6660.00%
2020/07/0700.00423.0021.60-41,505-0.27%
2020/07/0600.00223.0823.15-21,476-0.14%
2020/07/0100.00124.0024.00-11,420-0.07%
2020/06/29122.0000.0022.3011,4060.07%
2020/06/1800.00123.9022.85-11,372-0.07%
2020/06/17525.29925.5125.35-41,350-0.30%
2020/06/161225.00126.2025.90111,2940.85%
2020/06/151923.4500.0024.20191,2071.57%
2020/05/2900.00218.5018.50-2973-0.21%
2020/05/28217.60518.0818.50-3978-0.31%
2020/05/27323.7500.0019.4539470.32%
2020/05/2500.00219.6519.65-2935-0.21%
2020/05/22717.8100.0017.9079300.75%
2020/05/1900.00113.5013.50-1812-0.12%
2020/05/18112.3000.0012.3017940.13%
2020/05/0800.002012.0011.80-20778-2.57%
2020/04/292011.3800.0011.30207132.80%
2020/02/2600.00214.0014.05-2321-0.62%
2020/02/25212.65111.9512.8012640.38%
2020/02/1000.001010.3710.40-10166-6.00%
2020/02/0500.00210.3010.35-2160-1.24%
2020/02/041211.2100.0010.80121567.66%
2019/12/1200.0019.669.65-162-1.59%
2019/12/1119.7900.009.771641.56%
2019/08/2600.0059.809.94-5148-3.37%
2019/06/0500.0019.739.76-198-1.01%
2018/04/2000.00220.0520.20-2362-0.55%
2018/04/16521.8000.0021.3553291.52%
2018/04/13523.7000.0023.7053021.65%
2018/04/10222.8500.0022.8521891.05%
2018/03/2700.00119.7019.00-1186-0.54%
2018/02/27119.1000.0018.9012080.48%
2018/02/23219.0500.0019.3022030.98%
2018/01/0300.001018.9018.75-10181-5.50%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音